163 related articles for article (PubMed ID: 11745271)
21. Secondary non-Hodgkin's lymphoma after treatment for childhood cancer.
Eguiguren JM; Ribeiro RC; Pui CH; Hancock ML; Pratt CB; Head DR; Crist WM
Leukemia; 1991 Oct; 5(10):908-11. PubMed ID: 1961025
[TBL] [Abstract][Full Text] [Related]
22. Development of second primary malignancy in patients with non-Hodgkin lymphoma: a nationwide population-based study.
Chien SH; Liu CJ; Hong YC; Teng CJ; Hu YW; Ku FC; Yeh CM; Chiou TJ; Gau JP; Tzeng CH
J Cancer Res Clin Oncol; 2015 Nov; 141(11):1995-2004. PubMed ID: 25971624
[TBL] [Abstract][Full Text] [Related]
23. Impact on second malignancy risk of the combined use of radiation and chemotherapy for lymphomas.
Lavey RS; Eby NL; Prosnitz LR
Cancer; 1990 Jul; 66(1):80-8. PubMed ID: 2354413
[TBL] [Abstract][Full Text] [Related]
24. Second Cancer Risk Up to 40 Years after Treatment for Hodgkin's Lymphoma.
Schaapveld M; Aleman BM; van Eggermond AM; Janus CP; Krol AD; van der Maazen RW; Roesink J; Raemaekers JM; de Boer JP; Zijlstra JM; van Imhoff GW; Petersen EJ; Poortmans PM; Beijert M; Lybeert ML; Mulder I; Visser O; Louwman MW; Krul IM; Lugtenburg PJ; van Leeuwen FE
N Engl J Med; 2015 Dec; 373(26):2499-511. PubMed ID: 26699166
[TBL] [Abstract][Full Text] [Related]
25. Non-Hodgkin's lymphoma after primary Hodgkin's disease in the German Hodgkin's Lymphoma Study Group: incidence, treatment, and prognosis.
Rueffer U; Josting A; Franklin J; May M; Sieber M; Breuer K; Engert A; Diehl V;
J Clin Oncol; 2001 Apr; 19(7):2026-32. PubMed ID: 11310450
[TBL] [Abstract][Full Text] [Related]
26. Second malignancies after Ewing's sarcoma: radiation dose-dependency of secondary sarcomas.
Kuttesch JF; Wexler LH; Marcus RB; Fairclough D; Weaver-McClure L; White M; Mao L; Delaney TF; Pratt CB; Horowitz ME; Kun LE
J Clin Oncol; 1996 Oct; 14(10):2818-25. PubMed ID: 8874344
[TBL] [Abstract][Full Text] [Related]
27. Treatment-related myelodysplasia and acute leukemia in non-Hodgkin's lymphoma patients.
Armitage JO; Carbone PP; Connors JM; Levine A; Bennett JM; Kroll S
J Clin Oncol; 2003 Mar; 21(5):897-906. PubMed ID: 12610191
[TBL] [Abstract][Full Text] [Related]
28. Moderate increase of secondary hematologic malignancies after myeloablative radiochemotherapy and autologous stem-cell transplantation in patients with indolent lymphoma: results of a prospective randomized trial of the German Low Grade Lymphoma Study Group.
Lenz G; Dreyling M; Schiegnitz E; Haferlach T; Hasford J; Unterhalt M; Hiddemann W
J Clin Oncol; 2004 Dec; 22(24):4926-33. PubMed ID: 15611507
[TBL] [Abstract][Full Text] [Related]
29. Leukemia following low-dose total body irradiation and chemotherapy for non-Hodgkin's lymphoma.
Travis LB; Weeks J; Curtis RE; Chaffey JT; Stovall M; Banks PM; Boice JD
J Clin Oncol; 1996 Feb; 14(2):565-71. PubMed ID: 8636772
[TBL] [Abstract][Full Text] [Related]
30. Therapy-related Secondary Malignancy After Treatment of Childhood Malignancy: Cases from a Single Center.
Ueda T; Migita M; Itabashi T; Tanabe Y; Uchimura R; Gocho Y; Yamanishi M; Kobayashi F; Yoshino M; Fujita A; Yamanishi S; Kaizu K; Hayakawa J; Asano T; Maeda M; Itoh Y
J Nippon Med Sch; 2019 Sep; 86(4):207-214. PubMed ID: 31061250
[TBL] [Abstract][Full Text] [Related]
31. Subsequent malignancies among long-term survivors of Hodgkin lymphoma and non-Hodgkin lymphoma: a pooled analysis of German cancer registry data (1990-2012).
Baras N; Dahm S; Haberland J; Janz M; Emrich K; Kraywinkel K; Salama A
Br J Haematol; 2017 Apr; 177(2):226-242. PubMed ID: 28106907
[TBL] [Abstract][Full Text] [Related]
32. Low incidence of second neoplasms among children diagnosed with acute lymphoblastic leukemia after 1983.
Bhatia S; Sather HN; Pabustan OB; Trigg ME; Gaynon PS; Robison LL
Blood; 2002 Jun; 99(12):4257-64. PubMed ID: 12036851
[TBL] [Abstract][Full Text] [Related]
33. Age-time risk patterns of solid cancers in 60 901 non-Hodgkin lymphoma survivors from Finland, Norway and Sweden.
Lorenzo Bermejo J; Pukkala E; Johannesen TB; Sundquist J; Hemminki K
Br J Haematol; 2014 Mar; 164(5):675-83. PubMed ID: 24528128
[TBL] [Abstract][Full Text] [Related]
34. Second neoplasms following high-dose chemotherapy and autologous stem cell transplantation for malignant lymphomas: a report of six cases in a cohort of 171 patients from a single institution.
Oddou S; Vey N; Viens P; Bardou VJ; Faucher C; Stoppa AM; Chabannon C; Camerlo J; Bouabdallah R; Gastaut JA; Maraninchi D; Blaise D
Leuk Lymphoma; 1998 Sep; 31(1-2):187-94. PubMed ID: 9720728
[TBL] [Abstract][Full Text] [Related]
35. Risk of second malignancy after non-Hodgkin's lymphoma: a British Cohort Study.
Mudie NY; Swerdlow AJ; Higgins CD; Smith P; Qiao Z; Hancock BW; Hoskin PJ; Linch DC
J Clin Oncol; 2006 Apr; 24(10):1568-74. PubMed ID: 16520465
[TBL] [Abstract][Full Text] [Related]
36. Incidence of secondary acute myelogenous leukemia after treatment of childhood acute lymphoblastic leukemia.
Kreissman SG; Gelber RD; Cohen HJ; Clavell LA; Leavitt P; Sallan SE
Cancer; 1992 Oct; 70(8):2208-13. PubMed ID: 1394053
[TBL] [Abstract][Full Text] [Related]
37. Second malignant neoplasms in childhood cancer survivors in a tertiary paediatric oncology centre in Hong Kong, China.
Sun WF; Cheng FW; Lee V; Leung WK; Shing MK; Yuen PM; Li CK
Chin Med J (Engl); 2011 Nov; 124(22):3686-92. PubMed ID: 22340225
[TBL] [Abstract][Full Text] [Related]
38. Late mortality, secondary malignancy and hospitalisation in teenage and young adult survivors of Hodgkin lymphoma: report of the Childhood/Adolescent/Young Adult Cancer Survivors Research Program and the BC Cancer Agency Centre for Lymphoid Cancer.
Bhuller KS; Zhang Y; Li D; Sehn LH; Goddard K; McBride ML; Rogers PC
Br J Haematol; 2016 Mar; 172(5):757-68. PubMed ID: 26727959
[TBL] [Abstract][Full Text] [Related]
39. Risk of second malignant neoplasms after cyclophosphamide-based chemotherapy with or without radiotherapy for non-Hodgkin lymphoma.
Xu Y; Wang H; Zhou S; Yu M; Wang X; Fu K; Qian Z; Zhang H; Qiu L; Liu X; Wang P
Leuk Lymphoma; 2013 Jul; 54(7):1396-404. PubMed ID: 23101661
[TBL] [Abstract][Full Text] [Related]
40. Second malignancies after treatment of childhood non-Hodgkin lymphoma: a report of the Berlin-Frankfurt-Muenster study group.
Moser O; Zimmermann M; Meyer U; Klapper W; Oschlies I; Schrappe M; Attarbaschi A; Mann G; Niggli F; Spix C; Kontny U; Klingebiel T; Reiter A; Burkhardt B; Woessmann W
Haematologica; 2021 May; 106(5):1390-1400. PubMed ID: 32299903
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
